France OKays new jab

Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer Meatloaf singer

PARIS: The French national authority of health (HAS) officially approved the Nuvaxovid vaccine for Covid-19 on Friday (Saturday in Manila). “The data from various studies show the high efficiency of the Nuvaxovid vaccine against the symptomatic forms of Covid-19 (nearly 90 percent), and in particular against severe forms with nearly 100 percent efficiency,” HAS said in a statement. Nuvaxovid, manufactured by American biotechnology company Novavax, is suitable for people over the age of 18, with a delay between doses of three weeks, HAS said.